If you have any question, please feel free to email us. We will touch with you as soon as possible.
CAS:63121-00-6
Source:India/Europe
Qualifications:USDMF/-/-/-/-
Name | Oxaliplatin |
---|---|
Chinese name | 奥沙利铂 |
Cas Number | 63121-00-6 |
Source | India/Europe |
Qualifications | USDMF/-/-/-/- |
The original research was Debiopharm, which was listed in the United States in 2002 and in China and Japan in 2004. Oxaliplatin (L-OHP), as the third-generation platinum anti-tumor drug, is mainly used in clinical treatment for colorectal cancer, breast cancer, pancreatic cancer, lung cancer, and ovarian cancer. Its mechanism of action takes DNA as the target site, and platinum ions form cross-links with DNA strands, thereby blocking its replication and transcription. Compared with cisplatin (DDP), its DNA binding kinetics characteristics are obviously different. The DNA binding kinetics characteristics of cisplatin are biphasic. It takes 15 minutes for fast-phase binding and 4-8 hours for slow-phase binding. Completely bind to DNA within 15 minutes. Platinum drugs have high anti-tumor activity. Many basic and clinical trials have fully proved that they are effective when used alone or in combination with other drugs. Therefore, they are widely used in the treatment of ovarian cancer, colorectal cancer and lung cancer and other solid tumors. Very important basic chemotherapy drugs.
Hot Tags: oxaliplatin api, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Dapoxetine API, Tavaborol API, Lercanidipine Hydrochloride API, Perindopril Arginine API, Fondaparinux API, Vardenafil API
Tel:+86-020-61855200-902
Fax:+86-020-66392525
Email:info@upharm.cn
Address:12th floor, No. 181, Kexue Avenue, Huangpu District, Guangzhou, China